Beirut Wire
  • Home
  • The Sunday Brief
  • Opinion
  • Politics
  • Economy
  • Society
  • Culture
  • Business
  • World
  • Markets
  • About
Sign in Subscribe

World

Moderna’s Personalized mRNA Cancer Vaccine Clears a Major Phase 3 Hurdle

Moderna’s Personalized mRNA Cancer Vaccine Clears a Major Phase 3 Hurdle

Moderna and Merck’s personalized mRNA cancer vaccine has delivered positive Phase 3 results in high-risk melanoma, reducing the likelihood of the disease returning when combined with Keytruda.
Beirut Wire 04 Sep 2026

Subscribe to Beirut Wire

One email every Sunday morning. Everything distilled in a 5 minute read. No spam. Unsubscribe anytime.
  • Sign up
Beirut Wire © 2026. Powered by Ghost